Sale!

Comprehensive Tumor Panel 270 Genes Test

Original price was: 8,000 د.إ.Current price is: 6,000 د.إ.

-25%

The Comprehensive Tumor Panel 270 Genes Test, offered by DNA Labs UAE for a cost of 6000 AED, is a cutting-edge diagnostic tool designed to provide an extensive genetic analysis of a patient’s tumor. This advanced test examines 270 different genes known to be associated with various cancers, helping to pinpoint specific genetic mutations that may be driving the growth of the tumor. By identifying these mutations, the test can guide oncologists in selecting the most effective treatment strategies tailored to the individual’s genetic profile, potentially improving treatment outcomes. This comprehensive approach not only aids in the selection of targeted therapies but also helps in understanding the prognosis and risk of recurrence. Conducted in the state-of-the-art facilities of DNA Labs UAE, this test represents a significant step forward in personalized cancer care, offering hope for more effective and targeted cancer treatments.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

Comprehensive Tumor Panel 270 Genes Test

Welcome to DNA Labs UAE, where we offer the Comprehensive Tumor Panel 270 Genes Test at a cost of AED 6000.0.

Test Details

The Comprehensive Tumor Panel 270 Genes Test is a genetic test that analyzes mutations in 270 genes associated with various types of cancer. This panel includes genes that are commonly mutated in solid tumors, such as breast, lung, colon, and prostate cancer, as well as genes associated with rare cancers.

The test is typically performed on tumor tissue samples obtained through a biopsy or surgery. The results of the test can help guide treatment decisions, as certain genetic mutations may respond better to specific therapies.

Some of the genes included in the panel are:

  • TP53: a tumor suppressor gene commonly mutated in many types of cancer
  • KRAS: a gene that regulates cell growth and is frequently mutated in lung, colon, and pancreatic cancer
  • EGFR: a gene that regulates cell growth and is commonly mutated in lung cancer
  • BRAF: a gene that regulates cell growth and is commonly mutated in melanoma and colorectal cancer
  • PIK3CA: a gene that regulates cell growth and is commonly mutated in breast and ovarian cancer
  • PTEN: a tumor suppressor gene commonly mutated in many types of cancer
  • HER2: a gene that regulates cell growth and is commonly overexpressed in breast cancer
  • RET: a gene that regulates cell growth and is commonly mutated in thyroid cancer

Overall, the Comprehensive Tumor Panel 270 Genes provides a comprehensive assessment of genetic mutations in cancer, allowing for more personalized treatment plans based on the individual’s unique genetic profile.

Test Components and Price

The Comprehensive Tumor Panel 270 Genes Test is priced at AED 6000.0.

Sample Condition

The test requires a blood sample collected in an EDTA tube.

Report Delivery

The test results will be delivered within 21 working days.

Method

The test is conducted by an Oncologist.

Test Type

The Comprehensive Tumor Panel 270 Genes Test falls under the category of Doctor Oncology.

Test Department

The test is conducted in the Molecular Diagnostics department.

Pre Test Information

No specific pre-test instructions are provided.

For more information or to schedule an appointment, please contact DNA Labs UAE.

Test Name Comprehensive Tumor Panel 270 Genes Test
Components
Price 6000.0 AED
Sample Condition Blood EDTA Tube
Report Delivery 21 Working Days
Method Oncologist
Test type
Doctor Oncology
Test Department: MOLECULAR DIAGNOSTICS
Pre Test Information
Test Details

The Comprehensive Tumor Panel 270 Genes is a genetic test that analyzes mutations in 270 genes associated with various types of cancer. This panel includes genes that are commonly mutated in solid tumors, such as breast, lung, colon, and prostate cancer, as well as genes associated with rare cancers.

The test is typically performed on tumor tissue samples obtained through a biopsy or surgery. The results of the test can help guide treatment decisions, as certain genetic mutations may respond better to specific therapies.

Some of the genes included in the panel are:

– TP53: a tumor suppressor gene commonly mutated in many types of cancer

– KRAS: a gene that regulates cell growth and is frequently mutated in lung, colon, and pancreatic cancer

– EGFR: a gene that regulates cell growth and is commonly mutated in lung cancer

– BRAF: a gene that regulates cell growth and is commonly mutated in melanoma and colorectal cancer

– PIK3CA: a gene that regulates cell growth and is commonly mutated in breast and ovarian cancer

– PTEN: a tumor suppressor gene commonly mutated in many types of cancer

– HER2: a gene that regulates cell growth and is commonly overexpressed in breast cancer

– RET: a gene that regulates cell growth and is commonly mutated in thyroid cancer

Overall, the Comprehensive Tumor Panel 270 Genes provides a comprehensive assessment of genetic mutations in cancer, allowing for more personalized treatment plans based on the individual’s unique genetic profile.